This is a preview of subscription content, log in via an institution to check access.
References
Davis, G. L. Initial results with recombinant interferon alfa-2b in patients with chronic hepatitis C: the United States experience. Gut 34 (suppl. 2) (1993) 109–111.
Hoofnagle, J. H., Di Bisceglie, A. M., Shindo, M. Antiviral therapy of hepatitis C — present and future. J. Hepatol. 17 (suppl. 3) (1993) 30–36.
Metreau, J. M., and the French Group for the Study of NANB/C Chronic Hepatitis Treatment Results of long term interferon treatment in non A non B/C chronic active hepatitis. Gut 34 (suppl. 2) (1993) 112–113.
Dimipoulou, M., Fafoutis, K., Basiliou, K., Ketikoglou, J., Karvountzis, G. Interferon alfa-2b for decompensated liver disease caused by either chronic hepatitis B or C: preliminary results of a pilot study. Gut 34 (suppl. 2) (1993) 104–105.
Genesca, J., Esteban, J. I., Quer, J., Viladomin, L. L., Gonzales, A., Esteban, R., Guardia, J. Hepatitis C virus markers in patients with acute post-transfusion hepatitis treated with interferon alfa-2b. Gut 34 (suppl. 2) (1993) 62–63.
Hwang, S.-J., Lee, S.-D., Lee, Y.-H. W., Wu, J.-C., Chan, C.-Y., Huang, Y.-S., Wang, Y.-J., Lo, K. J. A randomized controlled clinical trial of recombinant interferon α-2b in the treatment of acute post-transfusion hepatitis C: a preliminary report. J. Gastroenterol. Hepatol. 8 (suppl. 1) (1993) 92–98.
Tassopoulos, N. C., Koutelou, M. G., Papatheodoridis, G., Polychronaki, H., Delladetsima, J., Giannikakis, T., Todoulos, A., Toliopoulos, A., Hatzakis, A. Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis. Gut 34 (Suppl. 2) (1993) 130–132.
Hagiwara, H., Hayashi, N., Kasahara, A., Mita, E., Takehara, T., Fusamoto, H., Komdada, T. Three cases of posttransfusion hepatitis C treated with interferon-alpha. Confirmation of a carrier state by detection of hepatitis C virus RNA after interferon therapy. Dig. Dis. Sci. 37 (1992) 631–634.
Colombo, M., Lampertico, P., Rumi, M. Multicentre randomised controlled trial of recombinant interferon alfa-2b in patients with acute non-A, non-B/type C hepatitis after transfusion. Gut 34 (suppl. 2) (1993) 141.
Hayashi, N., Higashi, H., Kaminaka, K., Sugimoto, H., Esumi, M., Kamatsu, K., Hayashi, K., Sugitani, M., Suzuki, K., Tadao, O., Nozaki, C., Mizuno, K., Shikata, T. Molecular cloning and heterogeneity of the human hepatitis C virus (HCV) genome. J. Hepatol. 17 (suppl. 3) (1993) 94–107.
Di Bisceglie, A. M., Goodman, Z. D., Ishak, K. G., Hoofnagle, J. H., Melpolder, J. J., Alter, H. J. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 14 (1991) 969–974.
De Alava, E., Camps, J., Pardo-Mindan, J., Garcia-Granero, M., Munoz, M., Sola, J., Cibeira, M. P., Contreras, F., Vasquez, J. J., Castilla, A., Prieto, J. Histological outcome of chronic hepatitis C treated with a 12-month course of lymphoblastoid alfa interferon. Liver 13 (1993) 73–79.
Scheuer, P. J., Ashrafzadeh, P., Sherlock, S., Brown, D., Dusheiko, G. M. The pathology of hepatitis C. Hepatology 15 (1992) 567–571.
Donahue, J. G., Munoz, A., Ness, P. M., Drago, C., Tagger, A., Ribero, M. L., Realdi, G. The declining risk of post-transfusion hepatitis C virus infection. N. Engl. J. Med. 327 (1992) 369–373.
Takahashi, M., Yamada, G., Miyamoto, R, Doi, T., Endo, H., Tsuji, T. Natural course of chronic hepatitis C. Am. J. Gastroenterol. 88 (1993) 240–243.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Palmović, D., Kurelac, I. & Crnjaković-Palmović, J. The treatment of acute post-transfusion hepatitis C with recombinant interferon-alpha. Infection 22, 222–223 (1994). https://doi.org/10.1007/BF01716714
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01716714